Genetix Biotherapeutics
MA - SomervilleBiotechnology
Focus: Genetix Biotherapeutics is a private gene therapy company headquartered in Somerville, MA, specializing in cellular extraction and reintroduction for rare blood disorders and malignancies. The company operates at clinical stage with multiple Phase 2–3 programs in beta-thalassemia, sickle cell disease, and other rare indications.
Profile data last refreshed 2h ago · AI intelligence enriched 2w ago
Funding Stage
PRIVATE
Open Jobs
15+1 this month
Stable — net +1 jobs in 30d
7 added, 6 removed. Backfill posture.
Should You Work at Genetix Biotherapeutics?
AI assessmentGenetix Biotherapeutics is a high-risk, high-reward early-stage opportunity for gene therapy specialists willing to accept financial uncertainty in exchange for direct involvement in late-stage clinical and commercial scaling.
Why Work Here
- Leading-edge lentiviral gene therapy platform with multiple Phase 3 programs (LentiGlobin BB305 for beta-thalassemia, Lenti-D for CALD, bb1111 for sickle cell disease) offering exposure to transformative cell and gene therapy modalities.
Data completeness
3/9 — Basic
Company HealthStrong
Pipeline
Late-stage
4 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Evaluation of Impact of Disease on Quality of Life, Education and Socio-professional Integration of
Sickle-cell Disease (SCD)Safety and efficacy assessments
Sickle Cell DiseaseHelp build intelligence for Genetix Biotherapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.